New Weight Loss Pill Cuts Body Weight By 20%
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
Category : Search result: UK pharmaceutical investment
NHS Must Reverse Medicines Investment Decline - Minister
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
AstraZeneca shifts cancer drug production from UK to Ireland
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Trump Threatens NHS Drug Pricing: UK Faces US Medicine Costs
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
Google's £1bn UK AI Investment Boost Amid Trump Visit
Chancellor Rachel Reeves secures landmark £1 billion Google investment in UK AI infrastructure, marking a significant vote of confidence in Britain's tech economy during high-profile Trump meeting.
Big Pharma's Billion-Pound Bet on Post-Trump UK
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
Scotland Accuses UK Government of Economic Sabotage Over Yorkshire Deal
John Swinney claims Westminster is deliberately undermining Scottish economy by diverting a major foreign investment to Yorkshire, sparking a major constitutional row.
AstraZeneca Pauses £500m Cambridge HQ Investment
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
Common Meds Linked to Youth Suicide Surge, Study Finds
Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg
AstraZeneca Pauses £200m Cambridge Research Investment
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
Sanofi CEO: UK is 'terrible place' for medicines
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
Ohanian Leads $1BN Chelsea Bid With Huge Women's Team Investment
Serena Williams' husband, Alexis Ohanian, headlines a landmark $1 billion investment consortium to revolutionise Chelsea FC Women, aiming to create a global football powerhouse and challenge US dominance.
Australia's Offshore Wind Exodus: Investors Flee Renewable Projects
Major international investors are abandoning Australia's offshore wind projects, dealing a devastating blow to the nation's clean energy transition and 2030 renewable targets. Discover the regulatory chaos and political uncertainty causing this crisis.
MSD to create 125+ new R&D jobs in London expansion
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
Trump pressured FDA to fast-track Covid vaccine before election
Exclusive report reveals Donald Trump pressured US health officials to accelerate vaccine approval for political gain ahead of the 2020 election, according to congressional investigation.
Mounjaro KwikPens launch without price reduction
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Congress Grills Pharma Over Child Vaccine-Linked Illnesses
A tense US Congressional hearing investigates a surge in severe neurological illnesses in children following vaccination, as lawmakers demand answers from pharmaceutical executives.
Wegovy Jab Sends Novo Nordisk Shares Soaring Past £400bn
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
Germany seizes illegal Wegovy shipment in Frankfurt
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Oakland's Property Market Offers Bargains for UK Investors
Exclusive investigation reveals how Oakland, California's plummeting house prices and strong dollar create a prime investment opportunity for British property hunters seeking value across the Atlantic.
Teen dies after starting new asthma medication
A 13-year-old girl from Northern Ireland tragically passed away just days after being prescribed a new asthma medication. Her devastated family is now demanding answers from health authorities.
New heart drug fails to outperform aspirin in major trial
Groundbreaking medical research reveals a new anti-inflammatory drug shows no significant advantage over traditional aspirin for heart attack prevention in most patients, challenging pharmaceutical expectations.
Warren Buffett's $11bn Kraft Heinz Investment Mistake
Billionaire investor Warren Buffett admits to a colossal $11bn error in judgement with Kraft Heinz, calling it a 'bad investment' in a rare public mea culpa.
Scotland's £500m Green Energy Investment in Highlands
The Scottish Government is spearheading a massive £500 million investment in the Highlands and Islands' green energy sector, partnering with a US private equity firm to create sustainable jobs and boost the local economy.
West Coast States Form Historic Vaccine Safety Alliance
In a landmark move for public health, California, Oregon, and Washington announce a unified 'West Coast Pact' to independently review COVID-19 vaccines, prioritising safety and science over political pressure.
Pfizer CEO: Trump Wanted Nobel Prize for Vaccine Role
The CEO of Pfizer has alleged that former President Donald Trump directly suggested he should be awarded a Nobel Prize for his role in the rapid development of the COVID-19 vaccine, a revelation that has sent shockwaves through political and scientific ci
Joe Rogan: Secret Link Between Antidepressants and Mass Shootings
Podcast titan Joe Rogan ignites a fierce debate by citing controversial research connecting widely prescribed antidepressants to the epidemic of mass shootings. This investigation delves into the science and the silenced studies.
Uganda Opens Pioneering mRNA Vaccine Facility
Uganda has inaugurated Africa's first major mRNA vaccine facility, a historic step towards medical self-reliance, combating diseases from COVID-19 to HIV, and reducing the continent's dependency on foreign pharmaceuticals.
RFK Jr Accuses CDC of Being 'Captured' by Big Pharma
US Presidential candidate Robert F. Kennedy Jr. launches a scathing attack on the CDC, accusing it of corruption and being a 'captured agency' of the pharmaceutical industry in a bombshell op-ed.
Police Hunt Woman Selling Fake Ozempic and Mounjaro
A nationwide manhunt is underway for a woman allegedly selling fake diabetes and weight-loss medications online. Authorities warn of severe health risks from counterfeit semaglutide injections.
Page 1 of 4